Pictet Asset Management
PRAX icon

Pictet Asset Management’s Praxis Precision Medicines PRAX Stock Holding History

Pictet Asset Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$98M Buy
291,689
+5,045
+2% +$1.6M 0.09% 234
2026
Q1 		$91.4M Buy
286,644
+46,056
+19% +$14.2M 0.1% 224
2025
Q4 		$71.1M Buy
+240,588
New +$44.8M 0.07% 267
2025
Q3 		– Sell
-79,143
Closed -$3.33M – 2076
2025
Q2 		$3.33M Buy
79,143
+555
+0.7% +$21.1K ﹤0.01% 823
2025
Q1 		$2.98M Buy
78,588
+33,161
+73% +$2.07M ﹤0.01% 854
2024
Q4 		$3.5M Buy
+45,427
New +$3.29M ﹤0.01% 856

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Pictet Asset Management's PRAX Position: Q2 2026 in Review

Pictet Asset Management increased its Praxis Precision Medicines (PRAX) stake by 1.8% in Q2 2026, buying an estimated $1.6M and bringing the position to 291,689 shares worth $98M. The position accounts for 0.09% of the portfolio, ranked #234.

Pictet Asset Management first reported a position in PRAX in Q4 2024 and has held it in 6 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Pictet Asset Management held 291,689 shares of Praxis Precision Medicines worth $98M as of Q2 2026.
  • Pictet Asset Management bought 5,045 Praxis Precision Medicines shares in Q2 2026, an estimated $1.6M.
  • Praxis Precision Medicines made up 0.09% of Pictet Asset Management's portfolio in Q2 2026, its #234 holding.
  • Pictet Asset Management first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 6 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.